Parameter
| Biomarker | miR-125b | Full name | microRNA-125b | Molecular Type | Microrna (miRNA) |
|---|---|---|---|---|---|
| Molecular Formula | Macromolecule | Molecular Weight | / | Core Functional Dimensions | Diagnosis, prognosis, |
| Disease | Adrenocortical Carcinoma | Disease Subtypes | / | ||
| Organ | Adrenal Cortex | Test Sample / Technology Platform | Serum/organization (RT - qPCR, NGS) | ||
| Pathobiological Mechanisms | Targeting inhibition of tumor suppressor gene expression, and promote the proliferation and metastasis of tumor cells | ||||
| Clinical Availability Status | Study phase: Low expression in adrenocortical carcinoma, diagnostic AUC of 0.82, correlated with overall survival | ||||
| Notes and Dynamics | Secrete body outside miR - 125 - b testing is expected to become a noninvasive diagnostic and monitoring samples | ||||